Sep 9, 2018
Now that the European Medical Device Regulation (MDR) is widely available, manufacturers and other industry participants can more accurately predict key issues that will affect them—including how and whether the scope of the new regulations covers their devices.
Note: This blog post was updated in October 2018 for accuracy.
The MDR text (see page 13 for the definition) as well as its accompanying Annex XVI (page 117) lay out clear indications as to which types of devices will have to comply with the new requirements and which will be covered by separate regulations. Before we go into detail, you might want to read last week’s high level overview of the MDR changes, or download our whitepaper on the MDR.
It is important to note that the MDR covers devices that previously fell under two separate European directives, the Medical Devices Directive (MDD) and the Active Implantable Medical Devices Directive (AIMDD); in vitro diagnostic devices will be covered by the new In Vitro Diagnostics Directive (IVDR).
The MDR defines the term “medical device” as any “instrument, apparatus, appliance, software, implant, reagent, material or other article” intended to be used for any of the following medical purposes:
The new regulation also specifies particular types of products that also qualify as medical devices requiring CE Marking:
Of course, manufacturers currently certified to market their devices in the European Union should familiarize themselves with the MDR text to determine whether their products do indeed fall under the scope of the new regulation, but some examples of products that do and do not fall under the MDR are provided below.
Yes | No |
|
|
|
|
|
|
In addition to products meeting the MDR’s definition of medical devices, Annex XVI of the new regulation lists groups of products that, despite having no intended medical purpose, must also meet MDR requirements.
The major product groups in Annex XVI include:
Accessories are products that are intended to enable a device to be used in accordance with its intended purpose or to assist the medical functionality of the medical device. They are covered in the scope of the Regulation, similar to the requirements in the Directives. As some products are now added to the definition of a medical device, their accessories will also be covered by the scope of the Regulation. Therefore it is necessary to verify all products used together with these new categories of medical devices to identify accessories as defined in the MDR.
Some examples:
For the majority of the products it will be relatively straightforward to determine their status. However, Emergo expects that this Regulation will soon create its own list of borderline products. Emergo is interested in the devices and accessories that you consider medical devices, or that should not be covered by this scope. So please send us your examples, with a clear description of the intended purpose and mode of action, so we can analyze the consequences of the new definition.
In some instances, determining whether a product qualifies as a medical device under the MDR will not be a cut and dry affair. As manufacturers begin compliance efforts under the new regulations, some product types will elicit questions from manufacturers that will require further clarification from Brussels.
One such question likely to arise pertains to products listed in Annex XV and accessories. By definition, accessories must be used in relation to the medical purpose of a device, but the products in Annex XV have no medical purpose. So, does this mean that no accessories exist for Annex XVI devices?
Publication of draft In Vitro Diagnostic Regulations (IVDR) in the European Union, which occurred earlier than anticipated, provides IVD manufacturers with a clearer idea of how new requirements will impact their CE Marking certification and compliance.